NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
4.4M
Enterprise Value 3
-1.71M
Trailing P/E
N/A
Forward P/E 1
12.10
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.25
Price/Book (mrq)
0.53
Enterprise Value/Revenue 3
-0.48
Enterprise Value/EBITDA 6
0.18

Trading Information

Stock Price History

Beta (5Y Monthly) 2.03
52-Week Change 3-87.80%
S&P500 52-Week Change 325.78%
52 Week High 311.5000
52 Week Low 30.7400
50-Day Moving Average 31.0362
200-Day Moving Average 31.7191

Share Statistics

Avg Vol (3 month) 3342.81k
Avg Vol (10 day) 3819k
Shares Outstanding 53.63M
Float 889.03k
% Held by Insiders 116.50%
% Held by Institutions 119.06%
Shares Short (Dec 30, 2019) 4105.44k
Short Ratio (Dec 30, 2019) 40.85
Short % of Float (Dec 30, 2019) 413.71%
Short % of Shares Outstanding (Dec 30, 2019) 42.90%
Shares Short (prior month Nov 28, 2019) 4389.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Mar 31, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -274.67%
Operating Margin (ttm)-269.58%

Management Effectiveness

Return on Assets (ttm)-46.55%
Return on Equity (ttm)-102.89%

Income Statement

Revenue (ttm)3.53M
Revenue Per Share (ttm)2.99
Quarterly Revenue Growth (yoy)22.10%
Gross Profit (ttm)995k
EBITDA -9.37M
Net Income Avi to Common (ttm)-9.74M
Diluted EPS (ttm)-8.2540
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.15M
Total Cash Per Share (mrq)1.97
Total Debt (mrq)1.05M
Total Debt/Equity (mrq)13.31
Current Ratio (mrq)4.12
Book Value Per Share (mrq)2.28

Cash Flow Statement

Operating Cash Flow (ttm)-10.04M
Levered Free Cash Flow (ttm)-6.83M